1. Home
  2. PRAA vs PRTA Comparison

PRAA vs PRTA Comparison

Compare PRAA & PRTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRAA
  • PRTA
  • Stock Information
  • Founded
  • PRAA 1996
  • PRTA 2012
  • Country
  • PRAA United States
  • PRTA Ireland
  • Employees
  • PRAA N/A
  • PRTA N/A
  • Industry
  • PRAA Finance: Consumer Services
  • PRTA Biotechnology: Pharmaceutical Preparations
  • Sector
  • PRAA Finance
  • PRTA Health Care
  • Exchange
  • PRAA Nasdaq
  • PRTA Nasdaq
  • Market Cap
  • PRAA 790.6M
  • PRTA 809.8M
  • IPO Year
  • PRAA N/A
  • PRTA N/A
  • Fundamental
  • Price
  • PRAA $18.25
  • PRTA $9.70
  • Analyst Decision
  • PRAA Strong Buy
  • PRTA Buy
  • Analyst Count
  • PRAA 2
  • PRTA 9
  • Target Price
  • PRAA $32.00
  • PRTA $54.57
  • AVG Volume (30 Days)
  • PRAA 328.8K
  • PRTA 605.6K
  • Earning Date
  • PRAA 05-05-2025
  • PRTA 05-07-2025
  • Dividend Yield
  • PRAA N/A
  • PRTA N/A
  • EPS Growth
  • PRAA N/A
  • PRTA N/A
  • EPS
  • PRAA 1.79
  • PRTA N/A
  • Revenue
  • PRAA $1,114,524,000.00
  • PRTA $135,157,000.00
  • Revenue This Year
  • PRAA $7.67
  • PRTA N/A
  • Revenue Next Year
  • PRAA $5.67
  • PRTA $131.71
  • P/E Ratio
  • PRAA $10.26
  • PRTA N/A
  • Revenue Growth
  • PRAA 38.87
  • PRTA 47.92
  • 52 Week Low
  • PRAA $15.94
  • PRTA $9.00
  • 52 Week High
  • PRAA $28.64
  • PRTA $25.42
  • Technical
  • Relative Strength Index (RSI)
  • PRAA 48.46
  • PRTA 34.03
  • Support Level
  • PRAA $16.02
  • PRTA $9.00
  • Resistance Level
  • PRAA $18.40
  • PRTA $10.07
  • Average True Range (ATR)
  • PRAA 1.16
  • PRTA 0.74
  • MACD
  • PRAA 0.15
  • PRTA 0.07
  • Stochastic Oscillator
  • PRAA 64.53
  • PRTA 28.00

About PRAA PRA Group Inc.

PRA Group Inc is a leader in acquiring and collecting nonperforming loans. The company returns capital to banks and other creditors to help expand financial services for consumers in the Americas, Europe, and Australia. It is also engaged in providing fee-based services on class action claims recoveries in the United States. The company's portfolio segments include; Core, which is engaged in purchasing and collecting nonperforming loans, which the originators have not chosen not to pursue, and the Insolvency segment which is engaged in purchasing and collecting nonperforming loans where the customer is involved in a bankruptcy proceeding.

About PRTA Prothena Corporation plc

Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).

Share on Social Networks: